Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer.

Ma, Yangyang; Xing, Yanli; Li, Hongmei; Liang, Bing; Li, Rongrong; Li, Jianyu; Li, Zhonghai; Lin, Mao; Niu, Lizhi

Ma, Yangyang; Xing, Yanli; Li, Hongmei; Liang, Bing; Li, Rongrong; Li, Jianyu; Li, Zhonghai; Lin, Mao; Niu, Lizhi.

Afiliação

Ma Y; Central Laboratory, Fuda Cancer Hospital, Guangzhou 510665, China.
Xing Y; Department of Oncology, Fuda Cancer Hospital, Guangzhou 510665, China.
Li H; Department of Oncology, Fuda Cancer Hospital, Guangzhou 510665, China.
Liang B; Department of Surgery and Anesthesia, Fuda Cancer Hospital, Guangzhou 510665, China.
Li R; Department of Ultrasound, Fuda Cancer Hospital, Guangzhou 510665, China.
Li J; Department of Surgery and Anesthesia, Fuda Cancer Hospital, Guangzhou 510665, China.
Li Z; Department of Radiology, Fuda Cancer Hospital, Guangzhou 510665, China.
Lin M; Central Laboratory, Fuda Cancer Hospital, Guangzhou 510665, China.
Niu L; Department of Oncology, Fuda Cancer Hospital, Guangzhou 510665, China.

J Oncol ; 2022: 3523769, 2022.

Article em En | MEDLINE | ID: mdl-35747123

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article